Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Food allergy drug developer Alladapt raised $119M in new funding By: Silicon Valley Business Journal via Business Journals June 22, 2022 at 18:52 PM EDT The funding comes as the Menlo Park company has begun a clinical trial and is building a manufacturing plant. Read More >> Related Stocks: Harbor Disruptive Innovation ETF Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Food allergy drug developer Alladapt raised $119M in new funding By: Silicon Valley Business Journal via Business Journals June 22, 2022 at 18:52 PM EDT The funding comes as the Menlo Park company has begun a clinical trial and is building a manufacturing plant. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
